<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1402233249
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MORPHINE HCl
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MORPHINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intrathecal, Intravenous, Intramuscular
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Controlled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        197.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LABORATOIRES STEROP NV" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LABORATOIRES STEROP NV
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 653]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            YAHMAA MEDICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            LABORATOIRES STEROP NV
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>MORPHINE HCl STEROP contains morphine that belongs to a group of medicines called opioid analgesics. MORPHINE HCl STEROP is used in adults and children for the relief of severe pain that cannot be relieved by other lower-level analgesics</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Do not use MORPHINE HCl STEROP<br />- If you are allergic to morphine or any of the other ingredients of this medicine (listed in section 7).<br />- If you have problems with your lungs or breathing such as &lsquo;hypoventilation&rsquo; or &lsquo;Chronic Obstructive Pulmonary Disease&rsquo; (COPD).<br />- If you are having an asthma attack.<br />- If you have sudden or recent liver problems.<br />- If you have recently had a head injury.<br />Leaflet<br />Page 2 sur 8<br />133 PIL EN 082020 SaudiArabia clear<br />- If you have something called &lsquo;phaeochromocytoma&rsquo;. This is a rare tumour which is not malignant.<br />- If you have fits (convulsions) or increased pressure inside your skull.<br />- If the person receiving this medicine is in a deep and prolonged unconscious state (coma).<br />- If you are addicted to alcohol or have recently consumed large amounts of alcohol.<br />- If you are taking or have in the last two weeks taken medication to treat depression such as monoamine-oxidase inhibitors (MAOIs).<br />- If you have paralytic ileus (loss of intestinal movement).<br />Do not use this medicine if any of the above apply to you. If you are not sure, talk to your doctor or health care provider.<br />Take special care with MORPHINE HCl STEROP<br />Check with your doctor before receiving your medicine if you:<br />- Are pregnant, trying to become pregnant or if you are breast-feeding.<br />- Have a particular lung problem that causes shortness of breath called emphysema or you have heart failure.<br />- Have shock (circulatory failure).<br />- Have asthma.<br />- Have gall bladder problems.<br />- Have long term (chronic) liver or kidney problems.<br />- Are a man who has prostate problems.<br />- Have an under-active thyroid gland or swelling of your skin (myxoedema).<br />- Have an unusually curved spine (kyphoscoliosis).<br />- Have bowel problems.<br />- Have an under-active adrenal gland (adrenocortical insufficiency).<br />- Are very overweight.<br />- Are or have ever been addicted to opioids, alcohol, prescription medicines, or illegal drugs.<br />- Have previously suffered from withdrawal symptoms such as agitation, anxiety, shaking or sweating, when you have stopped taking alcohol or drugs.<br />Talk to your doctor or health care provider if you experience any of the following symptoms while using MORPHINE HCl STEROP:<br />- Increased sensitivity to pain despite the fact that you are using increasing doses (hyperalgesia). Your prescriber will decide whether you will need a change in dose or a change in strong analgesic (&ldquo;painkiller&rdquo;).<br />- Weakness, fatigue, lack of appetite, nausea, vomiting or low blood pressure. This may be a symptom of your adrenal glands producing too little of a hormone called cortisol, and you may need to take a hormone supplement.<br />- Loss of libido (sex drive), difficulty getting an erection, menstrual periods stopping. This may be because of your body producing less sex hormones.<br />- You feel you need to use more of MORPHINE HCl STEROP to get the same level of pain relief, this may mean you are becoming tolerant to the effects of this medicine or are becoming addicted to it. Speak to your prescriber who will discuss your treatment and may change your dose or switch you to an alternative pain reliever.<br />Receiving this medicine regularly, particularly for a long time, can lead to addiction. Your prescriber should have explained how long you will be receiving it for and when it is appropriate to stop, how to do this safely.<br />Leaflet<br />Page 3 sur 8<br />133 PIL EN 082020 SaudiArabia clear<br />Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your prescriber about your treatment.<br />Addiction can cause withdrawal symptoms when you stop receiving this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop receiving the medicine suddenly as you will be more likely to experience withdrawal symptoms.<br />Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else.<br />Receiving higher doses or more frequent doses of opioid, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.<br />Morphine should not be administered preoperatively to children below the age of 1 year and should be given with extreme caution to neonates and premature infants.<br />If you are elderly or frail you will be given a reduced dosage, particularly if you have liver and kidney problems.<br />Please consult your doctor if any of the warnings mentioned above applies to you, or if any of them have in the past.<br />c. Using other medicines, herbal or dietary supplements<br />Tell your doctor or health care provider if you are using, have recently used or might use any other medicines.<br />In particular, tell your doctor if you are taking any of the following:<br />- Drugs that depress the nervous system (your doctor will know what these are).<br />- Other morphine derivatives and other painkillers (especially buprenorphine, nalbufine, or pentazocine).<br />- Medicines to help you sleep, make you feel less anxious or calm you down such as tranquilisers, hypnotics, sedatives, antipsychotics or tricyclic antidepressants.<br />- Receiving MORPHINE HCl STEROP together with sedative medicines such as benzodiazepines or related medicines increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, receiving MORPHINE HCl STEROP together with these types of medicines should only be considered when other treatment options are not possible.<br />However if your doctor does prescribe MORPHINE HCl STEROP together with sedative medicines, the dose and duration of taking the treatments together should be limited by your doctor.<br />Please tell your doctor about all sedative medicines you are taking, and follow your doctor&rsquo;s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor if you experience these symptoms.<br />- Anaesthetics - used during operations.<br />- Domperidone, metoclopramide or phenothiazine - medicines for feeling sick (nausea) and being sick (vomiting).<br />Leaflet<br />Page 4 sur 8<br />133 PIL EN 082020 SaudiArabia clear<br />- Mexiletine and esmolol - for controlling heart rhythm.<br />- Ritonavir - for HIV infections.<br />- Cimetidine - for stomach ulcers, indigestion or heartburn.<br />- Monoamine oxidase inhibitors (MAOIs) - for depression.<br />- Rifampicin - used to treat tuberculosis and other infections.<br />- Gabapentin - for epilepsy and long lasting pain caused by damage to the nerves.<br />Morphine hydrochloride solutions are incompatible with bases, iodine and iron, lead, manganese, silver, copper and zinc salts, tannic acid and potassium permanganate.<br />d. Using MORPHINE HCl STEROP with food, drink and alcohol<br />Avoid the consumption of alcoholic drinks and medicines containing alcohol: the sedative effects of morphine are enhanced by alcohol and may impair alertness.<br />e. Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. The doctor will then decide if this medicine is suitable for you.<br />If you are given MORPHINE HCl STEROP during pregnancy and become dependent on it, there is a risk that the new-born baby may also be dependent and suffer from withdrawal symptoms following delivery.<br />If you are given MORPHINE HCl STEROP during labour there is a risk that you could be sick and have breathing difficulties, or the baby could have difficulty starting breathing.<br />If you are breast-feeding, ask your doctor for advice before using this medicine. This medicine should not be used by nursing (breast-feeding) mothers.<br />f. Driving and using machines<br />You may feel drowsy while receiving this medicine. You should not drive or use machinery while receiving MORPHINE HCl STEROP for 48 hours after the last injection.<br />g. Important information about some of the ingredients of MORPHINE HCl STEROP<br />This medicine contains less than 1 mmol sodium (23mg) per ml, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your health care provider or doctor will give you the injection. Your doctor will decide the correct dosage for you and how and when the injection will be given.<br />This medicine can be administered to you by injection under the skin, in a muscle or into a vein, and also by an intrathecal (epidural or intraspinal) and intraventricular injection.<br />a. If you use more MORPHINE HCl STEROP than you should<br />Since the injection will be given to you by a doctor or health care provider, it is unlikely that you will be given too much. If you think you have been given too much, you must tell the person giving you the injection.<br />If you used too much MORPHINE HCl STEROP, contact your doctor or the Poison Center.<br />Leaflet<br />Page 5 sur 8<br />133 PIL EN 082020 SaudiArabia clear<br />Tell your doctor or health care provider immediately if any of the following symptoms of overdose occur: drowsiness, which may be followed by breathing difficulties, contraction of the pupils, fall in blood pressure, fall in body temperature, coma.<br />b. If you forget to use MORPHINE HCl STEROP<br />If you think that an injection has been missed, speak to your doctor or health care provider.<br />Do not use a double dose to make up for a forgotten dose.<br />c. If you stop using MORPHINE HCl STEROP<br />You should always check with your doctor before the treatment is stopped. It is possible that you could become dependent on morphine and have withdrawal symptoms if it is stopped suddenly. Your doctor will explain you how to gradually taper the dose.<br />Signs of withdrawal include dilation of the pupils, continuous tearing and nasal discharge, sneezing, muscle tremor, weakness, sweating, anxiety, irritability, insomnia, nausea, vomiting, diarrhoea, dehydration, concentration of the blood and rise in the white blood cell count, abdominal and muscle cramps, accelerated heart rate, elevation of body temperature, and rise in blood pressure.<br />If you have any further questions on the use of this medicine, ask your doctor orhealth care provider.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, MORPHINE HCl STEROP can cause side effects, although not everybody gets them.<br />The frequency of possible side effects is defined as follows:<br />&bull; Very[QA1] common: may affect more than 1 in 10 patients.<br />&bull; Uncommon: may affect up to 1 in 100 patients.<br />&bull; Rare: may affect up to 1 in 1,000 patients.<br />&bull; Not known: frequency cannot be estimated from available data.<br />The following side effects may happen with this medicine:<br />Allergic[QA2] reactions (frequency not known)<br />If you have a severe allergic reaction, stop using this medicine and see a doctor straight away. Signs may include swelling of the mouth and face, difficulty breathing, dizziness and skin reactions such as rash and itching.<br />Tell your doctor straight away if you notice the following side effects. You may need urgent medical treatment:<br />&bull; Having a headache. This could be a sign of increased pressure inside your skull.<br />&bull; Feeling dizzy or unsteady when you stand up. This could be a sign of a temporary fall in blood pressure (orthostatic hypotension).<br />&bull; Shallow breathing, with a slow heartbeat (bradycardia) and cold clammy skin.<br />&bull; Feeling restless, irritable or having changes in your mood.<br />&bull; Stomach pain caused by spasm (cramps) of the tubes that carry urine to the bladder or bile to the intestines.<br />&bull; Dry mouth or sweating.</p><p>&bull; Seeing or hearing things that are not there (hallucinations) or feeling confused.<br />&bull; Increased sensitivity to pain.<br />&bull; Dependence and addiction (see section &ldquo;How do I know if I am addicted&rdquo;).<br />The frequency of above mentioned side effects is not known.<br />&bull; Difficulty breathing (not linked to an allergic reaction) (rare).<br />Drug Withdrawal (uncommon)<br />When you stop using MORPHINE HCl STEROP, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.<br />How do I know if I am addicted?<br />If you notice any of the following signs whilst using MORPHINE HCl STEROP, it could be a sign that you have become addicted.<br />&bull; You need to use the medicine for longer than advised by your prescriber.<br />&bull; You feel you need to use more than the recommended dose.<br />&bull; You are using the medicine for reasons other than prescribed.<br />&bull; When you stop using the medicine you feel unwell, and you feel better once using the medicine again.<br />If you notice any of these signs, it is important you talk to your doctor.<br />Other side effects<br />Very common:<br />&bull; Feeling sick (nausea) or being sick (vomiting).<br />&bull; Constipation, which can be treated with appropriate laxatives.<br />Uncommon:<br />&bull; Feeling drowsy.<br />&bull; Sedation, nightmare, excitation.<br />&bull; Itching, urticaria, skin rashes.<br />&bull; Pain or irritation at the injection site.<br />Rare:<br />&bull; Difficulty in passing water (urine).<br />Frequency not known:<br />&bull; Flushing of your face.<br />&bull; Your heart rate getting faster (tachycardia) or slower (bradycardia) or fast and uneven (palpitations).<br />&bull; Lower body temperature (hypothermia).<br />&bull; Lowered sex drive or erection problems.<br />&bull; Muscles feeling tense.<br />&bull; The black circle in the centre of your eyes (pupil) getting smaller (miosis), blurred or double vision or other changes in vision.<br />&bull; Vertigo.</p><p>If you get any side effects, talk to your doctor or health care provider. This includes any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.<br />Protect from light. Store below 25&deg;C.<br />Do not use MORPHINE HCl STEROP after the expiry date which is stated on the pack and the ampoule after &quot;EXP&quot;.<br />Do not use MORPHINE HCl STEROP if you notice the presence of particles in the ampoule or if the solution is not clear.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance of this medicine is morphine hydrochloride 10mg/1ml.<br />The other ingredients are sodium chloride, hydrochloric acid (for pH adjustment) and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                MORPHINE HCl STEROP is an aqueous, clear, uncoloured to lightly yellow solution for injection, free of visible particles.
MORPHINE HCl STEROP is available in boxes containing 10 or 100 glass ampoules of 1ml.
Prescription: On medical prescription.
MORPHINE HCl STEROP follows the law for narcotics
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Laboratoires Sterop<br />Avenue de Scheut, 46-50 - 1070 Brussels &ndash; Belgium<br />Phone: +32 2 524 39 66<br />Fax: +32 2 521 60 71</p><p>&nbsp;</p><p>Yahmaa Medical Company<br />69, Al-kindi Plaza, Diplomatic Quarter</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                082020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>مورفین ھیدروكلوراید ستیروب یحتوي على مورفین الذي ینتمي إلى مجموعة من الأدویة تسمى المُ سكّ نات الأفیونیة. یستخدم<br />مورفین ھیدروكلوراید ستیروب في البالغین والأطفال للتخفیف من الآلام الشدیدة التي لا یمكن تخفیفھا عن طریق المسكنات<br />الأخرى منخفضة المستوى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>3دیارولكوردیھ نیفروم بوریتس مادختسا لبق .<br />أ- لا تستخدم ستیروب مورفین ھیدروكلوراید:<br />.( - اذا كانت لدیك حساسیة من المورفین أو أي من المحتویات الأخرى لھذا الدواء (مدرجة في القسم 7<br />- اذا كنت تعاني من مشاكل بالرئتین أو التنفس مثل قلة التھویة أو مرض انسداد الرئة المزمن.<br />- اذا كنت تعاني من نوبات الربو.<br />- اذا كنت تعاني من مشاكل مفاجئة أو حدیثة بالكبد.<br />- اذا كنت تعاني من اصابة بالجمجمة.<br />- كیدل ناك اذإ ثیبخ ریغ ردان مرو اذھ .&quot;متاوقلا مرو&quot;.<br />- ) تابون نم يناعت تنك اذإكتمجمج لخاد طغضلا ةدایز وأ (تاجنشت.<br />- صخشلا ناك اذإف ةلاح يف ءاودلا اذھ ىقلتی يذلادقنا (ةبوبیغ) ةلیوطو ةقیمع يعولل.<br />- نمدم تنك اذإ ًا ا ىلعرخؤم تلوانت وأ لوحكل ًا ھنم ةریبك تایمك.<br />- م لثم بائتكلاا جلاعل ءاود نییضاملا نیعوبسلأا يف تلوانت وأ لوانتت تنك اذإزیدیسكوأ نیماونوم تاطبث (MAOIs).<br />- (ءاعملأا ةكرح نادقف) يللش صولع كیدل ناك اذإ.<br />لا تستخدم ھذا الدواء إذا كان أي مما سبق ینطبق علیك. إذا لم تكن متأكد اً ، فتحدث إلى طبیبك أو مقدم الرعایة الصحیة.<br />ب- خوتى عم رذحلا بوریتس دیارولكوردیھ نیفروم<br />كبیبط رشتسا ت لبقلوان تنك اذإ ءاودلا:<br />- ًلاماح ةعضرم وأ لمحلا نیلواحت وأ.<br />- بلقلا يف روصق كیدل وأ ةئرلا خافتنا ىمست سفنتلا يف قیض ببست ةنیعم ةیوئر ةلكشم كیدل.<br />- (ةیومدلا ةرودلا لشف) ةمدص كیدل.<br />- وبرلاب باصم.<br />- ةرارملا يف لكاشم كیدل.<br />- زم) دملأا ةلیوط لكاشم كیدلىلكلا وأ دبكلا يف (ةنم.<br />- جر ًلا اتاتسوربلا يف لكاشم نم يناعی.<br />- (ةیطاخملا ةمذولا) دلجلا يف مروت وأ ةیقردلا ةدغلا طاشن يف روصق نم يناعت.<br />- (يرقفلا دومعلا سوقت) يداع ریغ لكشب ينحنم يرقف دومع كیدل.<br />- ءاعملأا يف لكاشم كیدل.<br />- رظكلا ةدغلا طاشن صقن نم يناعترشق روصق) ةیة (رظكلا.<br />- ةیاغلل نزولا ةدایز نم يناعت.<br />- دقنمدأ نأو قبست ةروظحملا ریقاقعلا وأ ةفوصوملا ةیودلأا وأ لوحكلا وأ ةینویفلأا داوملا ىلع.<br />- قباس تیناع ًا باحسنلاا ضارعأ نم لاا وأ قلقلا وأ جایھلا لثمشاعتر ملا وأ لوحكلا لوانت نع فقوتلا دنع قرعتلا وأتاردخ.<br />تحدث إلى طبیبك أو مقدم الرعایة الصحیة إذا واجھت أی اً من الأعراض التالیة أثناء استخدام مورفین ھیدروكلوراید ستیروب:<br />- تم تاعرج لوانت نم مغرلاب مللأل ةیساسحلا ةدایز ررقیس .(ملأتلا طرف) ةدیازكبیبط رجلا يف رییغت ىلإ جاتحتس تنك اذإ ام وأ ةع رییغتىلا ُمس ّك(&quot;مللأل نكسم&quot;) يوق ن.<br />- لا ضارعأ نم اذھ نوكی دق .مدلا طغض ضافخنا وأ ءيق ، نایثغ ، ةیھشلا ةلق ، قاھرإ ، فعضدج لیلقلا جتنت يتلا ةیرظكلا ددغ ًا ينومرھ لمكم لوانت ىلإ جاتحت دقو ، لوزیتروكلا ىمسی نومرھ نم.<br />- تنلاا ةبوعص ، (يسنجلا عفادلا) ةیسنجلا ةبغرلا نادقف تانومرھل كمسج جاتنإ ببسب اذھ نوكی دق .ةیرھشلا ةرودلا فقوت ، باصلقأ ةیسنج.<br />- نم دیزملا مادختسا ىلإ ةجاحب كنأ رعشت بوریتس دیارولكوردیھ نیفروم ، ملالآا فیفخت نم ىوتسملا سفن ىلع لوصحلل دق اذھوم تحبصأ كنأ ينعی ًلاّمحت ل ًانمدم تحبصأ وأ ءاودلا اذھ تاریثأت .ھیلع ىلإ ثدحتكبیبط وأ كتعرج ریغی دقو كجلاع شقانیس يذلایكھجو ىلإ مادختسا ُم ّكسمللأل لیدب ن.<br />، ةلیوط ةرتفل ةصاخو ، ماظتناب ءاودلا اذھ لوانت يدؤی دق نأ بجی .نامدلإا ىلإكل حضوی كبیبط مادختسلاا ةرتف نوكی ىتموبسانم ًا افقوتل مادختسلاا نع مأب كلذب مایقلا ةیفیكو ،نا.<br />جاحب تنأف ، اذھ ثدح اذإ .مللأل ةیساسح رثكأ ءاودلا اذھ ةعرج ةدایز كلعجت دق ، ةردان تلااح يف ىلإ ثدحتلا ىلإ ةكبیبط نعكجلاع.<br />ةبوعصو ، قرلأا باحسنلاا ضارعأ لمشت نأ نكمی .ءاودلا اذھ لوانت نع فقوتلا دنع باحسنلاا ضارعأ نامدلإا ببسی نأ نكمی جیھتلاو ، مونلا ، (بلقلا ناقفخ) بلقلا تابرضب روعشلاو ، قلقلاو ، ةراثلإاو ،لاب روعشلاو ، مدلا طغض ةدایزوكّعوت ، لاھسلإاو ، ّرعتلا وأ ةشعرلاو ، شاعترلااو ، ةیھشلا نادقفو شقانیس .قكبیبط یجیردت كتعرج لیلقت ةیفیك كعم ًا فاقیإ لبق مادختسا لا نم .ءاود نع فقوتت لاأ مھملامادختسا اباحسنلاا ضارعأب ةباصلإل ةضرع رثكأ نوكتس ثیح ةأجف ءاودل.<br />ةینویفلأا داوملا مادختسا بجی ھفصو مت نیذلا كئلوأ لبق نم طقفا رخآ صخش يلأ كئاود طعت لا .مھل.<br />ت يدؤی دقلوان راركت رثكأ تاعرج وأ ىلعأ تاعرج ًا فلإا يدؤی نأ نكمی .نامدلإا رطخ ةدایز ىلإ ةینویفلأا داوملا نم يف طار مادختسلااو ةدئاز ةعرج ىلإ مادختسلاا ءوسو/ ةافولا وأ.<br />لبق نیفروملا ءاطعإ يغبنی لا ءارجا ةدلاولا يثیدحل دیدش رذحب هؤاطعإ بجیو ةدحاو ةنس نع مھرامعأ لقت نیذلا لافطلأل ةحارجلا ُخلا لافطلأاو ّدج.<br />نسم تنك اذإ ًا فیعض وأ ًا إ ةصاخ ، ةضفخم ةعرج كؤاطعإ متیس ،ىلكلاو دبكلا يف لكاشم نم يناعت تنك اذ.<br />یرجى استشارة طبیبك إذا كانت أي من التحذیرات المذكورة أعلاه تنطبق علیك ، أو إذا كان أي منھا في الماضي.<br />ج. استخدام أدویة أخرى أو أعشاب أو مكملات غذائیة<br />ةیحصلا ةیاعرلا مدقم وأ كبیبط ربخأ رخؤم تمدختسا وأ مدختست تنك اذإ ًا ىرخأ ةیودأ يأ مدختست دق وأ.<br />صوصخلا ھجو ىلع یأ لوانتت تنك اذإ كبیبط ربخأ ، ًا يلی امم:<br />- ام كبیبط ملعیس) يبصعلا زاھجلا طبثت يتلا ةیودلأا يھ هذھ ةیودلأا(.<br />- خ) ىرخلأا مللأا تانكسمو ىرخلأا نیفروملا تاقتشم وأ نیفوبلان وأ نیفرونیربوب ةصا(نیسوزاتنب.<br />- یودلأاثم كتئدھت وأ لقأ قلقب رعشت كلعجت ، مونلا ىلع كدعاست يتلا ة ُملا ، تامونملا ، تائدھملا لتانّكس أ ناھذلا تاداضم ، وقلحلا ةیثلاث بائتكلاا تاداضمة.<br />- رولكوردیھ نیفروم لوانت نإاا رطخ نم دیزی ةلصلا تاذ ةیودلأا وأ تانیبیزایدوزنبلا لثم ةئدھملا ةیودلأا عم بوریتس دی ساعنل بجی ، ببسلا اذھل .ةایحلل ةددھم نوكت دقو ةبوبیغو (يسفنت طیبثت) سفنتلا يف تابوعصولأاذخ لوانت نأ رابتعلااب نیفرومرولكوردیھا بوریتس دی ةیودلأا نم عاونلأا هذھ عمنوكی ةنكمم ریغ ىرخلأا جلاعلا تارایخ نوكت امدنع طقف.<br />كبیبط فصو اذإ ، كلذ عمو ولكوردیھ نیفرومرا بوریتس دیبط ددحی نأ بجیف ، ةئدھملا ةیودلأا عم لوانت ةدمو ةعرج كبیعم تاجلاعلا ًا.<br />ءاقدصلأا غلابإ دیفملا نم نوكی دق .بثك نع كبیبط تایصوت عبتاو ، اھلوانتت يتلا ةئدھملا ةیودلأا عیمج نع كبیبط ربخأ كلضف نموكذملا ضارعلأاو تاملاعلاب ةیارد ىلع اونوكیل براقلأا وأضارعلأا هذھ تھجاو اذإ كبیبطب لصتا .هلاعأ ةر.<br />- ریدختلا ةیودأ- تایلمعلا ءانثأ مدختست.<br />- نیزایثونیف وأ دیماربولكوتیم ، نودیریبمود- نایثغلاب روعشلل ةیودأ (ءيقلا) ضرملاو.<br />- و نیتیلیسكیم إ لولومس- بلقلا تابرض يف مكحتلل.<br />- ریفانوتیر- انملا صقن سوریف ىودعلةیرشبلا ةع.<br />- نیدیتیمیس- ةدعملا ةقرحو مضھلا رسعو ةدعملا ةحرقل.<br />- ونوم تاطبثمأزیدیسكوأ نیم (MAOIs) - بائتكلال.<br />- نیسیبمافیر- ىرخأ تاباھتلاو لسلا جلاعل مدختسی.<br />- نیتنباباج- و عرصلا جلاعللآاباصعلأا فلت نع ةجتانلا دملأا ةلیوط ملا.<br />ردیھ لیلاحم قفاوتت لا ضمحو كنزلاو ساحنلا حلامأو ةضفلاو زینغنملاو صاصرلاو دیدحلاو دویلاو دعاوقلا عم نیفروملا دیرولكو.مویساتوبلا تانجنمربو كیناتلا<br />مادختسا .د رولكوردیھ نیفرومابوریتس دی مع الطعام والشراب والكحول<br />لوحكلا ىلع يوتحت يتلا ةیودلأاو ةیلوحكلا تابورشملا كلاھتسا بنجتیح ،نأ ث لوحكلا نم دیزی دقو نیفروملل ةئدھملا تاریثأتلاةظقیلا فعضت.<br />ھ. الحمل والرضاعة<br />ِتنك اذإ ُم وأ ًلاماح ، ةعضر وأ اذھ مادختسا لبق ةروشملا ىلع لوصحلل كبیبط يلأسا ، لفط باجنلإ نیططخت وأ لماح كنأ نیدقتعت دعب بیبطلا ررقیس .ءاودلاانم ءاودلا اذھ ناك اذإ ام كلذبس ًا كل.<br />ِكؤاطعإ مت اذإ رولكوردیھ نیفرومابوریتس دی ِتحبصأو لمحلا ءانثأ دمتعتنی ًادمتعم دیدجلا دولوملا نوكی نأ رطخ كانھف ، ھیلعةدلاولا دعب باحسنلاا ضارعأ نم يناعیو.<br />ِكؤاطعإ مت اذإ رولكوردیھ نیفرومابوریتس دی ھف ، ضاخملا ءانثأ نأ نم رطخ كانكّعوتلاب يباصت سفنتلا يف تابوعص نم يناعتوسفنتلا ءدب يف ةبوعص نم لفطلا يناعی دق وأ ،.<br />ِتنك اذإ نم ءاودلا اذھ مادختسا يغبنی لا .ءاودلا اذھ مادختسا لبق ةروشملا ىلع لوصحلل كبیبط يلأسا ، ةعاضرلا ةرتف يف لبقتاعضرملا تاھملأا.<br />و. القیادة واستخدام الآلات<br />ءانثأ ساعنلاب رعشت دق مادختسا يقلت ءانثأ تلالآا مادختسا وأ ةدایقلا مدع بجی .ءاودلا اذھ رولكوردیھ نیفرومابوریتس دی ةدمل٤۸ ریخلأا نقحلا دعب ةعاس.<br />تانوكم ضعب لوح ةمھم تامولعم .ز مورفین ھیدروكلوراید ستیروب<br />نم لقأ ىلع ءاودلا اذھ يوتحی1 ) مویدوص لومیلم۲۳ غلممينعی اذھو ، لم لكل ( يساسأ لكشب ھنأ مویدوصلا نم ٍلاخ</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ِقلا لخاد نقحلا قیرط نع كلذكو ، دیرول قوف) بار ُبلا لخاد نقحلاو (عاخنلا لخاد وأ ةیفاجلانیط.<br />مدختست تنك اذإ .أ رولكوردیھ نیفرومابوریتس دی أكثر مما ینبغي<br />رظن ًا نمف ، ةنقحلا كیطعی فوس ةیحصلا ةیاعرلا مدقم وأ بیبطلا نلأ كؤاطعإ متی نأ حجرملا ریغا نم رثكأ ةعرجمزلال تنك اذإ . ُأ دق كنأ دقتعتةنقحلا كاطعأ يذلا صخشلا ربخت نأ بجی ، مزلالا نم رثكأ تیطع.<br />نم ریثكلا تمدختسا اذإ رولكوردیھ نیفرومابوریتس دی مومسلا زكرم وأ كبیبطب لصتاف ،.<br />ةعرجلل ةیلاتلا ضارعلأا نم يأ ثودح ةلاح يف روفلا ىلع ةیحصلا ةیاعرلا مدقم وأ كبیبط ربخأ ھعبتی دق يذلا ساعنلا :ةدئازلاةبوبیغلاو ، مسجلا ةرارح ةجرد ضافخناو ، مدلا طغض ضافخناو ، نیعلا ةقدح صلقتو ، سفنتلا يف تابوعص.<br />مادختسا تیسن اذإ .ب مورفین ھیدروكلوراید ستیروب<br />ةیحصلا ةیاعرلا مدقم وأ كبیبط ىلإ ثدحتف ، ةنقح نادقف مت ھنأ دقتعت تنك اذإ.<br />تست لاةیسنملا ةعرجلا ضیوعتل ةفعاضم ةعرج مدخ.<br />مادختسا نع تفقوت اذإ .ج مورفین ھیدروكلوراید ستیروب<br />مت اذإ باحسنا ضارعأ كیدل نوكتو نیفروملا ىلع ًادمتعم حبصت نأ نكمملا نم .جلاعلا فاقیإ لبق كبیبط ةعجارم اًمئاد كیلع بجیت ةعرجلا صیلقت ةیفیك كبیبط كل حرشیس .ةأجف ھفاقیإاًیجیرد.<br />، فعضلاو ، تلاضعلا شاعرو ، سطعلاو ، فنلأا تازارفإو رمتسملا قزمتلاو ، نیعلا ةقدح عاستا باحسنلاا تاملاع لمشت .ءاضیبلا مدلا ایلاخ ددع عافتراو ، مدلا زیكرتو ، فافجلاو ، لاھسلإاو ، ءيقلاو ، نایثغلاو ، قرلأاو ، جیھتلاو ، قلقلاو ، قرعتلاوا يف تاجنشتومدلا طغض عافتراو مسجلا ةرارح ةجرد عافتراو بلقلا تاقد عراستو تلاضعلاو نطبل.<br />.ةیحصلا ةیاعرلا مدقم وأ كبیبط لأسا ، ءاودلا اذھ مادختسا لوح ىرخأ ةلئسأ يأ كیدل ناك اذإ</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>ارولكوردیھ نیفرومبوریتس دی راثآ ًا عیمجلا ىدل اھثودح مدع نم مغرلا ىلع ، ةیبناج.<br />ت دیدحت متیرارك يلاتلا وحنلا ىلع ةلمتحملا ةیبناجلا راثلآا:<br />&bull; نم رثكأ بیصی دق :ادج عئاش۱ لك نم۱۰ مىضر.<br />&bull; ىتح ىدل رھظت دق :ةعئاش ریغ۱ لك نم۱۰۰ .ضیرم<br />&bull; ىتح ىدل رھظت دق :ةردان۱ لك نم۱۰۰۰ مضیر.<br />&bull; تلا ریدقت نكمی لا :فورعم ریغرارك ةحاتملا تانایبلا نم.<br />ءاودلا اذھ عم ثدحت دق ةیلاتلا ةیبناجلا راثلآا:<br />تفاعلات تحسسیة (تكرار غیر معروف)<br />ّروت تاملاعلا لمشت دق .روفلا ىلع بیبطلا رشتساو ءاودلا اذھ مادختسا نع فقوتف ، دیدش يسسحت لعف در كیدل ناك اذإفلا م ھجولاو مةكحلاو يدلجلا حفطلا لثم ةیدلج لعف دودرو ةخودلاو سفنتلا ةبوعصو.<br />لجاع يبط جلاع ىلإ جاتحت دق .ةیلاتلا ةیبناجلا راثلآا تظحلا اذإ روفلا ىلع كبیبط ربخأ:<br />&bull; كتمجمج لخاد طغضلا ةدایز ىلع ةملاع اذھ نوكی دق .عادصلاب ةباصلإا.<br />&bull; تابثلا مدع وأ راودلاب روعشلا مدلا طغض ضافخنا) مدلا طغض يف تقؤم ضافخنا ىلع ةملاع اذھ نوكی دق .فوقولا دنع(يباصتنلاا.<br />&bull; دلجلاو (بلقلا ءطب) بلقلا تابرض ءطب عم ، لحضلا سفنتلا نوكی دراب بطر.<br />&bull; كجازم يف تاریغت ثودح وأ لاعفنلاا وأ ةحارلا مدعب روعشلا.<br />&bull; ا (تاصلقت) جنشت نع مجانلا ةدعملا ملأءاعملأا ىلإ ءارفصلا وأ ةناثملا ىلإ لوبلا لقنت يتلا بیبانلأ.<br />&bull; قرعتلا وأ مفلا فافج.<br />&bull; كابترلااب روعشلا وأ (ةسولھ) ةدوجوم ریغ ءایشأ عامس وأ ةیؤر.<br />&bull; مللأل ةیساسحلا ةدایز.<br />&bull; (&quot;نمدم يننأ فرعأ فیك&quot; مسق رظنا) نامدلإاو دامتعلاا.<br />كذملا ةیبناجلا راثلآا رتاوت نإفورعم ریغ هلاعأ ةرو.<br />&bull; درب ةطبترم ریغ) سفنتلا ةبوعصلا لعفلا(ردان) (يسسحت.<br />سحب الدواء (غیر شائع)<br />مادختسا نع فقوتت امدنع ، مونلا ةبوعص ، قرلأا لمشت يتلاو ، ءاودلا باحسنا ضارعأ ھجاوت دق ،بوریتس دیارولكوردیھ نیفروم ّیھتلاقلقلا ، ةراثلإا ، ج روعشلا ، مدلا طغض ةدایز ، (بلقلا ناقفخ) بلقلا تابرضب روعشلا ، كّعوتلاب ا ، ضرملا وأ ، لاھسلإ ، شاعترلااوأ ،ةشعرلا قرعتلا.<br />كیف أعرف أنني مُ دمِ ن؟<br />یأ تظحلا اذإ ًا مادختسا ءانثأ ةیلاتلا تاملاعلا نم بوریتس دیارولكوردیھ نیفروم قف ، ىلع ةملاع نوكت دنمدم تحبصأ كنأ ًا.<br />&bull; دلا مادختسا ىلإ ةجاحب تنأ ھب حصن امم لوطأ ةرتفل ءاو.كبیبط<br />&bull; اھب ىصوملا ةعرجلا نم رثكأ مادختسا ىلإ ةجاحب كنأ رعشت.<br />&bull; ةفوصوم ریغ بابسلأ ءاودلا مدختست تنأ.<br />&bull; ّعوتب رعشت ءاودلا مادختسا نع فقوتت امدنعنسحتلاب رعشتو ، ك ىرخأ ةرم ءاودلا مادختسا درجمب.<br />إذا لاحظت أی اً من ھذه العلامات ، فمن المھم أن تتحدث مع طبیبك.<br />أعراض جانبیة أخرى<br />ادج عئاش:<br />&bull; لاب روعشلاكّعوت (ءيقلا) ضرملا وأ (نایثغلا).<br />&bull; ةبسانملا تانیلملاب ھجلاع نكمی يذلا كاسملإا.<br />فولأم ریغ:<br />&bull; ساعنلاب روعشلا.<br />&bull; تنیكس ، (ةجعزم ملاحأ) سیباوك ،ةراثإ.<br />&bull; يدلج حفط ، ىرش ، ةكح.<br />&bull; نقحلا عقوم يف جیھت وأ ملأ.<br />ردان:<br />&bull; لوبتلا ةبوعص.<br />تلارارك فورعم ریغ:<br />&bull; ھجولا رارمحا.<br />&bull; بلقلا عرست) بلقلا تابرض لدعم عراست ٌعیرس وأ (بلقلا ءطب) هؤطابت وأ ( (ناقفخلا) مظتنم ریغو.<br />&bull; خنا ةجرد ضافمسجلا ةرارح.<br />&bull; يسنجلا عفادلا ضافخنا (ةبغرلا) باصتنلاا لكاشم وأ.<br />&bull; تلاضعلا رتوتب روعشلا.<br />&bull; رئادلالا) كینیع زكرم يف ءادوسلا ةةقدح ُّبقت) رغصأ حبصت (ةیؤرلا يف ىرخأ تارییغت وأ ةجودزم وأ ةیبابض ةیؤر ، (ةقدحلا ض.<br />&bull; ُدلاراو.<br />راثآ يأ نم يناعت تنك اذإةرشنلا</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دیعب ًا ظن نعلوانتمو ر لافطلأا.<br />نع ًادیعب ظفحی نم لقأ ةرارح ةجرد يف ظفحی .ءوضلا۲٥ ةیوئم ةجرد.<br />مدختست لا رومبوریتس دیارولكوردیھ نیف ةلوبملأاو ةوبعلا ىلع نودملا ةیحلاصلا ءاھتنا خیرات دعب دعب &quot;EXP&quot; .<br />مدختست لا بوریتس دیارولكوردیھ نیفروم أ ةلوبملأا يف تائیزج دوجو تظحلا اذإ ریغ لولحملا ناك اذإ وقئار.<br />لا تایافنلا وأ يحصلا فرصلا هایم يف ةیودلأا نم صلختلا يغبنی لا دعت مل يتلا ةیودلأا نم صلختلا ةیفیك نع يلدیصلا لأسا .ةیلزنمةئیبلا ةیامح ىلع دعاست نأ ریبادتلا هذھ نأش نمو .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أ. ماذا یحتوي مورفین ھیدروكلوراید ستیروب<br />دیرولكوردیھ نیفروم يھ ءاودلا اذھل ةلاعفلا ةداملا۱۰ غلمم /۱ لم.<br />المكونات الأخرى ھي كلورید الصودیوم ،حمض الھیدروكلوریك (لتعدیل الأس الھیدروجیني) ، ماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>بوریتس دیارولكوردیھ نیفروم يئام لولحم وھ نقحلل ّدعُم ،قئار ،نودب نول لئام نم يلاخ ، حتاف رفصأ ىلإةیئرملا تائیزجلا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مختبرات ستیروب&nbsp;</p><p>شركة یھماء الطبیة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            082020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1ml ampoule contents 10mg morphine hydrochloride.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1ml ampoule contents 10mg morphine hydrochloride
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.
Aqueous, clear, uncoloured to lightly yellow solution, free of visible particles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.1 Therapeutic indications<br />MORPHINE[QA1] HCl STEROP is indicated in adults and children for the treatment of intense pain that cannot be relieved by lower-level analgesics</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />The dose-efficacy-safety relationship varies considerably from one patient to another. It is therefore important to assess efficacy and safety frequently, and to adjust the dosage gradually as a function of the patient&#39;s needs. There does not appear to be a maximum dose, for as long as the adverse effects can be controlled.<br />As a guide, the table below summarises the order of dose equivalences as a function of the route of administration.<br />Route of administration<br />Equivalent of one dose<br />Oral route<br />1 mg<br />Subcutaneous route<br />equivalent to 1/2 to 1/3 mg<br />Intravenous route<br />equivalent to 1/2 to 1/3 mg<br />Epidural route<br />equivalent to 1/10 to 1/20 mg<br />Intrathecal route<br />equivalent to 1/50 to 1/200 mg<br />The simultaneous administration of morphine via two different routes of administration should be avoided because it exposes the patient to a risk of overdose due to the differing pharmacokinetics attached to different routes of administration.<br />&bull; Treatment of acute pain (notably postoperative pain):<br />Intravenous and subcutaneous routes<br />In adults:<br />Summary of product characteristics<br />Page 2 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />Morphine is usually administered via intravenous route in a fractionated manner (&quot;by titration&quot;) at a dose of 1 to 3 mg (mainly depending on the age of the patient) and approximately every 10 minutes, until satisfactory analgesia is achieved (or the onset of adverse effects) and while the patient is being continuously monitored. If relay treatment proves necessary, use can be made of either subcutaneous injections of 5 to 10 mg every 4 to 6 hours, or of intravenous patient-controlled analgesia with boluses of 0.5 to 1 mg followed by periods when injections are impossible (lockout periods) of about 10 minutes. Morphine by intravenous infusion (1 to 5 mg/hour) is usually reserved for patients under controlled ventilation in an intensive care unit.<br />Paediatric population:<br />Because of its painful nature, the subcutaneous route is not recommended in children.<br />Morphine is usually administered via slow intravenous route. An initial dose of 0.025 to 0.1 mg/kg (mainly depending on the age of the patient) is followed, if necessary, by a bolus of about 0.025 mg/kg every 5 to 10 minutes until satisfactory analgesia is achieved (or the onset of adverse effects) and while the patient is being continuously monitored. If relay treatment proves necessary, use can be made of a continuous intravenous infusion of 0.01 to 0.02 mg/kg/hour under supervision in a surgical recovery ward or intensive care unit.<br />Patient-controlled analgesia via the intravenous route can be implemented from the age of 6 years: the boluses are of 0.015 to 0.02 mg/kg, followed by periods when injections are impossible (lockout periods) of 10 to 15 minutes. This can be combined with a continuous dose of 0.005 to 0.02 mg/kg/hour.<br />Epidural route<br />In adults: 2 to 6 mg every 12 to 24 hours.<br />Paediatric population: 0.03 to 0.05 mg/kg, to be repeated if necessary as a function of clinical surveillance after 12 to 24 hours.<br />Intrathecal route<br />In adults: 0.1 to 0.2 mg every 12 to 24 hours.<br />&bull; Treatment of chronic pain (notably in the context of cancer):<br />Initial doses depend on the route of administration. When related to body weight, the doses in children and adults are equivalent.<br />Subcutaneous route<br />In patients who have not received prior treatment with oral morphine, the initial daily dose should be 0.5 mg/kg/day (classically 30 mg/day in adults), preferably via a continuous infusion or via injections repeated every 4 to 6 hours. .<br />In patients who have previously received oral morphine therapy, the initial daily dose should be half that of the oral dose administered. If the oral dose was insufficient, it is possible to switch immediately to a higher dosage.<br />Intravenous route<br />In patients who have not received prior treatment with oral morphine, the initial daily dose should be 0.3 mg/kg/day (classically 20 mg/day in adults), preferably via a continuous infusion.<br />Summary of product characteristics<br />Page 3 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />In patients who have received prior treatment with oral morphine, the initial daily dosage should be one third of the oral dose administered. If the oral dose was insufficient, it is possible to switch immediately to a higher dosage.<br />In patients presenting with pain of variable intensity over the day, it is possible to use a patient-controlled analgesia system; a continuous infusion (at the usual dosage) should be associated with self-administered boluses equivalent to approximately one hour of infusion. Each bolus should be followed by periods when injections are impossible (lockout periods) of a minimum of 10 minutes.<br />Epidural, intrathecal and intraventricular routes<br />In the case of chronic pain, these routes should be used when other methods of administration cause unacceptable adverse effects.<br />Comparison of initial dosages in function of the chosen route:<br />Route of administration envisaged<br />Parenteral equivalence<br />Epidural route<br />1/10th<br />Intrathecal route<br />1/100th<br />The intraventricular route is reserved for use by certain specialists at an initial dosage of approximately 0.1 to 0.2 mg/24 hours.<br />After the initiation of treatment, the dosage should be adjusted.<br />There should be no delay in adjusting a dose that proves ineffective. The patient should therefore be seen frequently, mainly at the start of treatment, for as long as the pain is not under control. If the pain is not controlled, the morphine daily dosage should be increased by about 30 to 50%. During this dose titration period, there does not appear to be an upper limit, for as long as any adverse effects can be controlled.<br />Method of administration<br />Solution for injection for subcutaneous, intramuscular, intravenous and intrathecal use.<br />The intramuscular route is not recommended as it is painful and does not have any pharmacokinetic advantages over the subcutaneous route.<br />The epidural, intrathecal and intraventricular routes require filtration of the solution through a 0.22 &mu;m filter prior to injection in order to prevent any particulate contamination after the ampoule has been opened.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4.3 Contraindications[AP3]
• Hypersensitivity to morphine or to any of the excipients listed in section 6.1.
• Respiratory depression.
• Obstructive airways disease.
• Paralytic ileus (see section 4.4).
• Acute hepatic disease.
• Acute alcoholism.
• Head injuries (see section 4.4).
• Coma (see section 4.4).
• Increased intracranial pressure (see section 4.4).
• Convulsive disorders.
• Concurrent administration with monoamine oxidase inhibitors or within two weeks of discontinuation of their use (see section 4.5).
• Patients with phaeochromocytoma. Morphine and some other opioids can induce the release of endogenous histamine and thereby stimulate catecholamine release.
• Acute asthma exacerbations (see section 4.4 for information relating to use in controlled asthma).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.4 Special[AP4] warnings and precautions for use<br />Risk from concomitant use of sedative medicines such as benzodiazepines or related drugs<br />Concomitant use of MORPHINE HCl STEROP and sedative medicines such as benzodiazepines or related drugs may result in sedation, respiratory depression, coma and death. Because of these risks, concomitant prescribing of morphine with these sedative medicines should be reserved for patients for whom alternative treatment options are not possible. If a decision is made to prescribe MORPHINE HCl STEROP concomitantly with sedative medicines, the lowest effective dose should be used, and the duration of treatment should be as short as possible.<br />The patients should be followed closely for signs and symptoms of respiratory depression and sedation. In this respect, it is strongly recommended to inform patients and their caregivers to be aware of these symptoms (see section 4.5).<br />Drug dependence, tolerance and potential for abuse<br />[QA5]Morphine is an opioid agonist and controlled drug.<br />For all patients, prolonged use of this product may lead to drug dependence (addiction), even at therapeutic doses. Dependence can appear after one or two weeks of treatment but in certain cases it can be observed after 2-3 days only. The risks are increased in individuals with current or past history of substance misuse disorder (including alcohol misuse) or mental health disorder (e.g., major depression).<br />Additional support and monitoring may be necessary when prescribing for patients at risk of opioid misuse.<br />A comprehensive patient history should be taken to document concomitant medications, including over-the-counter medicines and medicines obtained on-line, and past and present medical and psychiatric conditions.<br />Patients may find that treatment is less effective with chronic use and express a need to increase the dose to obtain the same level of pain control as initially experienced. Patients may also supplement their treatment with additional pain relievers. These could be signs that the patient is developing tolerance. The risks of developing tolerance should be explained to the patient.<br />Overuse or misuse may result in overdose and/or death. It is important that patients only use medicines that are prescribed for them at the dose they have been prescribed and do not give this medicine to anyone else.<br />Patients should be closely monitored for signs of misuse, abuse, or addiction.<br />The clinical need for analgesic treatment should be reviewed regularly<br />Drug withdrawal syndrome<br />Summary of product characteristics<br />Page 5 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />[QA6]Prior to starting treatment with any opioids, a discussion should be held with patients to put in place a withdrawal strategy for ending treatment with morphine.<br />Drug withdrawal syndrome may occur upon abrupt cessation of therapy or dose reduction. When a patient no longer requires therapy, it is advisable to taper the dose gradually to minimise symptoms of withdrawal. Tapering from a high dose may take weeks to months.<br />The opioid drug withdrawal syndrome is characterised by some or all of the following: restlessness, lacrimation, rhinorrhoea, yawning, perspiration, chills, myalgia, mydriasis and palpitations. Other symptoms may also develop including irritability, agitation, anxiety, hyperkinesia, tremor, weakness, insomnia, anorexia, abdominal cramps, nausea, vomiting, diarrhoea, increased blood pressure, increased respiratory rate or heart rate<br />If women receive this drug during pregnancy, there is a risk that their newborn infants will experience neonatal withdrawal syndrome.<br />Hyperalgesia<br />Hyperalgesia may be diagnosed if the patient on long-term opioid therapy presents with increased pain. This might be qualitatively and anatomically distinct from pain related to disease progression or to breakthrough pain resulting from development of opioid tolerance. Pain associated with hyperalgesia tends to be more diffuse than the pre-existing pain and less defined in quality. Symptoms of hyperalgesia may resolve with a reduction of opioid dose.<br />Adrenal insufficiency<br />Opioid analgesics may cause reversible adrenal insufficiency requiring monitoring and glucocorticoid replacement therapy. Symptoms of adrenal insufficiency may include e.g. nausea, vomiting, loss of appetite, fatigue, weakness, dizziness, or low blood pressure<br />Decreased sex hormones and increased prolactin<br />Long-term use of opioid analgesics may be associated with decreased sex hormone levels and increased prolactin. Symptoms include decreased libido, impotence or amenorrhoea<br />Acute chest syndrome (ACS) in patients with sickle cell disease (SCD)<br />Due to a possible association between ACS and morphine use in SCD patients treated with morphine during a vaso-occlusive crisis, close monitoring for ACS symptoms is warranted.<br />Hypotensive effect<br />The administration of morphine may result in severe hypotension in individuals whose ability to maintain homeostatic blood pressure has already been compromised by depleted blood volume or the concurrent administration of drugs such as phenothiazine or certain anaesthetics (see section 4.5).<br />Asthma<br />It has been suggested that opioids can be used with caution in controlled asthma. However, opioids are contraindicated in acute asthma exacerbations (see section 4.3).<br />Head injury and increased intracranial pressure<br />This medicine is contraindicated in patients with increased intracranial pressure, head injuries and coma (see section 4.3). The capacity of morphine to elevate cerebrospinal fluid pressure may be greatly increased in the presence of already elevated intracranial pressure produced by<br />Summary of product characteristics<br />Page 6 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />trauma. Also, morphine may produce confusion, miosis, vomiting and other adverse reactions which may obscure the clinical course of patients with head injury.<br />Abdominal conditions<br />Morphine must not be given if paralytic ileus is likely to occur (see section 4.3), or if the patient has bowel or obstructive biliary disease. Should paralytic ileus be suspected or occur during use, this medicine should be discontinued immediately.<br />Caution should be exercised where there is an obstructive bowel disorder, biliary colic, operations on the biliary tract, acute pancreatitis or prostatic hyperplasia.<br />If constipation occurs this may be treated with the appropriate laxatives.<br />Care should be exercised in patients with inflammatory bowel disease.<br />Morphine may obscure the diagnosis or clinical course of patients with acute abdominal conditions and complications following abdominal surgery.<br />Other precautions<br />&bull; [QA7]Morphine should be administered with care in patients suffering from hypothyroidism, in case of myasthenia gravis, in patients with corticosurrenal, liver and kidneys insufficiency, where there is reduced respiratory function, such as kyphoscoliosis, emphysema, cor pulmonale and severe obesity.<br />&bull; The [AP8]active metabolite Morphine-6-glucuronide may accumulate in patients with renal failure, leading to CNS and respiratory depression.<br />&bull; The respiratory function of patients with respiratory insufficiency should be monitored. Drowsiness constitutes a warning sign of decompensation.<br />&bull; In the event of hypovolemia, morphine may trigger a collapse. Hypovolemia should be corrected before injecting morphine.<br />Paediatric population<br />Morphine should not be administered preoperatively to children below the age of 1 year and should be given with extreme caution to neonates and premature infants. The initial dose must be reduced and the patient monitored in an Intensive Care Unit for the treatment of acute pain, with the preparation of an antidote.<br />Elderly<br />The dosage should be reduced in elderly or frail patients, particularly in the event of kidney and liver insufficiency, given their particular sensitivity to analgesic effects and central or digestive undesirable effects.<br />Injection<br />Do not use the solution if you notice the presence of particles in the ampoule or if it is not clear.<br />There is a risk of irritation or necrosis at the injection site when the administration is too rapid or when the injection has a too big volume. In order to reduce the risk of thrombophlebitis, it is recommended to change the injection site every 24 hours.<br />Excipients<br />This medicine contains less than 1 mmol sodium (23mg) per ml, that is to say essentially</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Monoamine oxidase inhibitors[AP9]<br />Monoamine oxidase inhibitors are known to interact with narcotic analgesics producing CNS excitation or depression with hyper- or hypotensive crisis, therefore their concomitant use with MORPHINE HCl STEROP is contraindicated (see section 4.3).<br />Alcohol<br />The sedative effect of morphine is enhanced by alcohol. Alertness may be impaired.<br />Other morphine derivatives and barbiturates<br />The risk of respiratory depression is increased.<br />CNS depressants<br />Depressant effects of morphine are enhanced by central nervous system depressants: anaesthetics, antipsychotics (e.g phenothiazines), anxiolytics, antidepressants and H1 antihistamines, neuroleptics, central antihypertensive agents, thalidomide, baclofen. The dose and duration of concomitant use should be limited (see section 4.4).<br />Sedative medicines such as benzodiazepines or related drugs<br />The concomitant use of opioids with sedative medicines such as benzodiazepines or related drugs increases the risk of sedation, respiratory depression, coma and death because of additive CNS depressant effect. The dose and duration of concomitant use should be limited (see section 4.4).<br />Morphine agonists-antagonists (buprenorphine, nalbufine, pentazocine)<br />Reduction of the analgesic or antitussive effect through the competitive blockade of receptors, with a risk of appearance of withdrawal syndrome.<br />Rifampicin<br />Rifampicin can reduce the serum concentration of morphine and decrease its analgesic effect. Clinical surveillance and adaptation if necessary of the morphine dosage during treatment with rifampicin and after its discontinuation are essential.<br />Gabapentin<br />Interactions have been reported when morphine and gabapentin are taken concomitantly. Reported interactions suggest an increase in opioid adverse events, the mechanism of which is not known. Caution should be taken where these medicines are prescribed concomitantly.<br />In a study involving healthy volunteers (N=12), when a 60 mg controlled-release morphine capsule was administered 2 hours prior to a 600 mg gabapentin capsule, mean gabapentin AUC increased by 44% compared to gabapentin administered without morphine. Therefore, patients should be carefully observed for signs of CNS depression, such as somnolence, and the dose of gabapentin or morphine should be reduced appropriately.<br />Ritonavir<br />Although there are no pharmacokinetic data available for concomitant use of ritonavir with morphine, ritonavir may increase the activity of glucuronyl transferases. Consequently, co-administration of ritonavir and morphine may result in decreased serum concentrations of morphine with possible loss of analgesic effectiveness.<br />Cimetidine<br />Summary of product characteristics<br />Page 8 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />Cimetidine inhibits the metabolism of morphine.<br />Esmolol<br />Morphine may increase plasma concentrations of esmolol.<br />Domperidone/metoclopramide<br />Opioid analgesics including morphine may antagonise the actions of domperidone and metoclopramide on gastro-intestinal activity.<br />Mexiletine<br />The absorption of mexiletine may be delayed by concurrent use of morphine.<br />Phenothiazine antiemetics<br />Phenothiazine antiemetics may be given with morphine. However, hypotensive effects have to be considered (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />A moderate quantity of data concerning pregnant women has not indicated that morphine exerts any malformative toxicity on the foetus/neonate. Animal studies have demonstrated reproductive toxicity (see section 5.3). As a safety measure, it is preferable not to use morphine during pregnancy.<br />Do not use morphine during the second phase of labour or in the case of a preterm infant. Morphine crosses the placental barrier and may cause respiratory depression in the neonate.<br />Habituation and withdrawal syndrome may appear in the neonate if the mother is a drug addict, with irritability, vomiting, convulsions and increased lethality. In this case, neonatal surveillance should be envisaged.<br />Breast-feeding<br />Insufficient information is available on the excretion of morphine into breast milk. A risk to the breastfed infant cannot be excluded. The discontinuation of either treatment or breastfeeding should be considered, while taking account of the benefits of breastfeeding to the infant and of the morphine therapy to the mother.<br />Fertility<br />Long term use of opioid analgesics can cause hypogonadism and adrenal insufficiency in both men and women. This is thought to be dose related and can lead to amenorrhoea, reduced libido, infertility and erectile dysfunction.<br />Animal studies have shown that morphine may reduce fertility (see section 5.3. preclinical safety data)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>MORPHINE HCl STEROP has a major influence on the ability to drive and use machines.<br />Because of impaired alertness and the depressant effect of morphine on the central nervous system, patients receiving this medicinal product will abstain from driving vehicles and using tools and/or machines for 48 hours after the last injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The hereafter mentioned side effects are classified by organ system and by frequency. Frequencies are defined as follows: very common (&ge; 1/10), uncommon: (&ge; 1/1.000, &lt; 1/100), rare (&ge; 1/10.000, &lt; 1/1.000), not known: cannot be estimated from the available data</p><p>a. Summary of the safety profile<br />The side-effects most commonly seen with morphine and other opioids are respiratory depression, nausea, vomiting, constipation, drowsiness and confusion. With long term use these symptoms generally lessen, although constipation frequently persists.<br />b. Tabulated list of adverse reactions<br />Organ system<br />Side effects<br />Frequency<br />Immune system disorders<br />Hypersensitivity, anaphylactoid reactions, anaphylactic reactions<br />Not known<br />Psychiatric disorders<br />Physical and psychological dependence (see section 4.4)<br />Very common<br />Confusional state, restlessness, altered mood, hallucination.<br />Not known<br />Nervous system disorders<br />Sedation, nightmare, excitation, drowsiness<br />Uncommon<br />Headache, increased intracranial pressure (see section 4.4), allodynia, hyperalgesia (see section 4.4).<br />Not known<br />Eye disorders<br />Blurred or double vision or other changes in vision, miosis.<br />Not known<br />Ear and labyrinth disorders<br />Vertigo<br />Not known<br />Cardiac disorders<br />Bradycardia, palpitations, tachycardia, orthostatic hypotension.<br />Not known<br />Vascular disorders<br />Facial flushing<br />Not known<br />Respiratory, thoracic[QA10] and mediastinal disorders<br />Respiratory depression (see section 4.4)<br />Rare<br />Gastrointestinal disorders<br />Constipation, nausea, vomiting<br />Very common<br />Dry mouth,<br />Not known<br />Hepatobiliary disorders<br />Biliary colic, biliary spasm<br />Not known<br />Skin and subcutaneous tissue disorders<br />Prurit, urticaria, contact dermatite, hyperhidrosis.<br />Uncommon<br />Musculoskeletal and connective tissue disorders<br />Muscle rigidity<br />Not known<br />Renal and urinary disorders<br />Dysuria, Difficulty urinating<br />Rare<br />Ureteral spasm.<br />Not known<br />Reproductive system and breast disorders<br />Decreased libido, erectile dysfunction<br />Not known<br />General disorders and administration site conditions<br />Pain or irritation at the injection site, drug withdrawal syndrome (see section 4.4 and section 4.6).<br />Uncommon<br />Drug tolerance (see section 4.4), hypothermia.<br />Not known<br />To report any side effect(s):<br />&bull; Saudi Arabia<br />Summary of product characteristics<br />Page 10 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States<br />Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be informed of the signs and symptoms of overdose and to ensure that family and friends are also aware of these signs and to seek immediate medical help if they occur.<br />Symptoms<br />Drowsiness, which can be a sign of respiratory insufficiency, marked miosis, hypotension, hypothermia, coma.<br />Emergency treatment<br />Emergency treatment should preferably be given in a specialised hospital and will include:<br />- Discontinuation of current morphine therapy,<br />- Cardio-respiratory resuscitation,<br />- Specific therapy with morphine antagonists: administer naloxone 0.4 mg by IV way, to be repeated every 2 to 5 minutes if necessary (0.4 to 4 mg in fractionated doses). In children, the initial dose is 0.01 mg/kg. If no effect is observed after 2 to 3 doses, the diagnosis can reasonably be questioned.<br />Precaution: in patients dependent on morphinomimetics, an injection of a too large quantity of naloxone may trigger a withdrawal syndrome. In these patients, naloxone must be injected cautiously at gradually increasing doses.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: morphinic analgesic<br />ATC code: N02AA01<br />Action on the central nervous system<br />Morphine is a potent, centrally-acting analgesic and narcotic in the opiate family. Its analgesic activity is dose-dependent. It may act on psychomotor behaviour and, depending on the doses and terrain, cause sedation or excitation. Even at therapeutic doses, morphine exerts a depressant action on the respiratory and cough centres. The respiratory depressive effects of morphine gradually diminish in the event of long-term administration. The action of morphine on the vomiting centre and on gastric emptying endows it with variable emetic properties. Finally, morphine causes myosis of central origin.<br />Action on smooth muscle<br />Summary of product characteristics<br />Page 11 sur 13<br />131 RCP EN 082020 SaudiArabia clear<br />Morphine diminishes the tone and the peristaltism of longitudinal fibres, and increases the tone of circular fibres, thus causing the spasm of sphincters (pyloric, ileocaecal valve [Bauhin&#39;s valve], anal sphincter, sphincter of Oddi, bladder sphincter).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption[QA11]<br />Blood resorption via the epidural route is more rapid than via the intrathecal route, hence a longer analgesic action via the intrathecal route. Via the epidural and intrathecal routes, supraspinal diffusion is delayed. The bioavailability of forms administered via the subcutaneous route is double that of forms administered by oral use. The bioavailability of forms administered via the intravenous route is at least triple that of forms administered by oral use.<br />Distribution<br />After resorption, the plasma protein binding to morphine reaches 30%. Morphine crosses the blood-brain barrier and the placenta.<br />Biotransformation<br />Morphine is largely metabolised into glucuronide conjugate derivatives which pass through an enterohepatic cycle. 6-glucuronide and normorphine are two active metabolites of the parent substance. The plasma half-life of morphine is 2 to 6 hours.<br />Elimination<br />Glucuronide conjugates are mainly excreted via the urine, following both glomerular filtration and tubular excretion. There is little excretion via the faeces (&lt;10%).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.3 Preclinical safety data<br />In vitro and in vivo preclinical experiments have demonstrated that morphine may be genotoxic.<br />In vitro studies showed that morphine did not cause any chromosomal abnormalities in mouse splenocytes. However, it was found that morphine provokes DNA fragmentation in a human lymphoma cell line. In vivo, during the micronucleus test in mice, it was seen that morphine caused an increase in the frequency of micronuclei in bone marrow cells and in immature red blood cells. Morphine can also cause chromosomal abnormalities in certain lymphocytes and spermatids. Long-term studies of the carcinogenic potential of morphine have not been performed. The importance of these data in humans is not known.<br />During animal experiments, morphine displayed teratogenic and embryotoxic characteristics and caused a drop in postnatal survival and behavioural and cerebral anomalies among progeny. Data obtained in humans have not demonstrated that any malformations or toxic effects on the foetus are linked to the therapeutic use of morphine.<br />In male rats, reduced fertility and chromosomal damage in gametes have been reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride.<br />131 RCP EN 082020 SaudiArabia clear<br />Hydrochloric acid (pH adjustment).<br />Water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicine product is incompatible with bases, iodine and iron, lead, manganese, silver, copper and zinc salts, tannic acid and potassium permanganate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep the ampoules in the outer carton in order to protect from light. Store below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1ml type I uncoloured glass ampoules. Packaging in boxes of 10 ampoules and 100 ampoules.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicine contains no antimicrobial preservatives and therefore cannot avoid the growth of microorganisms. The drug solution is intended for single and individual use.<br />Do not keep the unused remainder of the medicinal product for later administration.<br />Any unused medicinal product, waste material or remaining medicinal solution should be disposed of in accordance with local requirements.<br />In case of infusion, the medicinal solution and infusion set should be kept in an aseptic environment throughout the duration of the infusion according to the rules of clinical good practice recommendations. It is good clinical practice to use any medicinal solution prepared within 24 hours. At the end of the infusion, any medicinal solution and all infusion equipment containing this solution must be eliminated in compliance with current regulations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Laboratoires Sterop NV
Avenue de Scheut, 46-50 - 1070 Brussels – Belgium
Phone: +32 2 524 39 66
Fax: +32 2 521 60 71
E.mail: info@sterop.be
Local Marketing Authorisation Holder:
Yahmaa Medical Company
69, Al-kindi Plaza, Diplomatic Quarter
P.O. Box 67864, Riyadh 11517
Kingdom of Saudi Arabia
Telefax: +966 11 281 5152
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                082020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>